David O. Bates
- Nephrology top 0.5%
- Renal Diseases and Glomerulopathies 20
- Chronic Kidney Disease and Diabetes 15
- Geriatrics and Gerontology top 0.5%
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 20
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 23
-
- Angiogenesis and VEGF in Cancer 91
-
- Lymphatic System and Diseases 44
-
- Retinal Diseases and Treatments 23
-
- Multiple Sclerosis Research Studies 21
David O. Bates
309 papers receiving 16.1k citations
Hit Papers
Peers
Comparison fields: 5 of 187
- Nephrology 972
- Geriatrics and Gerontology 515
- Cancer Research 1.9k
- Critical Care and Intensive Care Medicine 624
- Immunology and Allergy 657
Countries citing papers authored by David O. Bates
This map shows the geographic impact of David O. Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David O. Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David O. Bates more than expected).
Fields of papers citing papers by David O. Bates
This network shows the impact of papers produced by David O. Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David O. Bates. The network helps show where David O. Bates may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David O. Bates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 12 | |
| 9 | 2020 | 17 | |
| 10 | In vivo measurement of increased vascular permeability after STZ induction of diabetes in rats by fluorescence angiography using the Micron IV | 2016 | 1 |
| 11 | 2014 | 150 | |
| 12 | 2012 | 54 | |
| 13 | 2012 | 34 | |
| 14 | VEGF-A(165)b Is Cytoprotective and Antiangiogenic in the Retina | 2010 | 1 |
| 15 | Recombinant Human VEGF(165)b Inhibits Experimental Choroidal Neovascularization | 2010 | 4 |
| 16 | Do electronic health records create more errors than they prevent? | 2008 | 2 |
| 17 | Do minority-serving physicians have comparable rates of use of electronic health records? | 2007 | 2 |
| 18 | Lack of active lymphangiogenesis in malignant melanoma despite increased lymphatic density and lymphangiogenic growth factor expression. | 2004 | 1 |
| 19 | Survey of Physicians' Experience Using a Handheld Drug Reference Guide | 2000 | 9 |
| 20 | 1978 | 86 |
About David O. Bates
David O. Bates is a scholar working on Immunology and Allergy, Nephrology and Ophthalmology, having authored 317 papers that have together received 16.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (91 papers), Lymphatic System and Diseases (44 papers), Cell Adhesion Molecules Research (23 papers), Retinal Diseases and Treatments (23 papers), Multiple Sclerosis Research Studies (21 papers), Renal Diseases and Glomerulopathies (20 papers), Cancer, Hypoxia, and Metabolism (20 papers) and Chronic Kidney Disease and Diabetes (15 papers). The work is most often cited by research in Nephrology (972 citations), Geriatrics and Gerontology (515 citations) and Cancer Research (1.9k citations). David O. Bates has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Steven J. Harper, Sebastian Oltean, Pamela J. Shaw, D A Shaw, Rebecca R. Foster, N.E.F. Cartlidge, D. Heaviside, Desmond G. Julian, Yan Qiu and F. E. Curry. Their work appears in journals such as Microcirculation, The Journal of Physiology, Clinical Science, American Journal of Physiology-Renal Physiology and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.